Detalles de la búsqueda
1.
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.
Int J Cancer;
153(6): 1227-1240, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260368
2.
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study.
Ann Hematol;
96(11): 1857-1866, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28905189
3.
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: a subgroup analysis from AIO-PK0104.
Acta Oncol;
54(7): 993-1000, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924969
4.
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104).
Gut;
62(5): 751-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22773551
5.
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.
Anticancer Drugs;
21(1): 94-100, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19770635
Resultados
1 -
5
de 5
1
Próxima >
>>